tiprankstipranks
Immutep Ltd (AU:IMM)
ASX:IMM
Australian Market
IMM
Immutep Ltd
RESEARCH TOOLSreports
Want to see AU:IMM full AI Analyst Report?

Immutep Ltd (IMM) Stock News & Sentiment

149 Followers
Immutep Faces Nasdaq Bid-Price Deficiency but Retains Listings as It Seeks Compliance
Premium
Company Announcements
Immutep Faces Nasdaq Bid-Price Deficiency but Retains Listings as It Seeks Compliance
2d ago
Immutep Halts Key Lung Cancer Trial but Pipeline Advances on Solid Cash Base
Premium
Company Announcements
Immutep Halts Key Lung Cancer Trial but Pipeline Advances on Solid Cash Base
2d ago
Immutep to Present New Eftilagimod Alfa Data at ASCO 2026
Premium
Company Announcements
Immutep to Present New Eftilagimod Alfa Data at ASCO 2026
10d ago
Immutep Ends Key Lung Cancer Trial but Stresses Strength of Pipeline
Premium
Company Announcements
Immutep Ends Key Lung Cancer Trial but Stresses Strength of Pipeline
24d ago
Insignia Financial Ceases to Be Substantial Holder in Immutep
Premium
Company Announcements
Insignia Financial Ceases to Be Substantial Holder in Immutep
1M ago
Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761
Premium
Company Announcements
Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761
1M ago
UBS Group Ceases to Be Substantial Shareholder in Immutep
Premium
Company Announcements
UBS Group Ceases to Be Substantial Shareholder in Immutep
1M ago
More AU:IMM News >

IMM News on the Web

Unusually active option classes on open April 15th
TipRanks News
Neutral
Immutep granted Orphan Drug Designation for eftilagimod alfa
TipRanks News
Neutral
Closing Bell: ASX falls flat as financials index flips red
StockHead
Bullish
Why this ASX biotech stock just rocketed 89% today
The Motley Fool
Neutral
Lunch Wrap: ASX settles as oil drops, Virgin lifts despite fuel pain
StockHead
Neutral
Top 10 at 11: ASX creeps higher as US-Iran ceasefire holds
StockHead
Neutral
Immutep Ends Key Lung Cancer Trial but Stresses Strength of Pipeline
TipRanks News
Neutral
Biocurious: Battered local biotech valuations provide golden opportunities
StockHead
Neutral

News Score - Last 7 Days

Neutral
AU:IMM
Sector Average
Media Buzz
This Week6 articles
Weekly Average2.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:IMM’s Media Buzz Sentiment?
6 articles about AU:IMM were published this week. In an average week, 2.25 articles are published.
    What is AU:IMM’s weekly average amount of articles?
    In an average week, 2.25 articles about AU:IMM are published.
      What is AU:IMM’s News Sentiment?
      100% of articles about AU:IMM were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week